lamivudine has been researched along with cyclosporine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Cisterne, JM; Duffaut, M; Durand, D; Henry, S; Icart, J; Rostaing, L | 1 |
| Han, DJ; Jung, YO; Lee, YS; Park, JS; Park, SK; Yang, WS | 1 |
| Ho, MC; Hu, RH; Lai, HS; Lai, MY; Lee, PH; Tsai, MK; Yang, PM | 1 |
| Bernard, B; Bitker, MO; Coriat, P; Mouquet, C; Opolon, P; Poynard, T; Thibault, V | 1 |
| Chao, TY; Dai, MS; Kao, WY; Shyu, RY | 1 |
| Yoshiba, M | 1 |
| Bo, P; Burra, P; Cillo, U; Loreno, M; Naoumov, N; Senzolo, M | 1 |
| Krawczuk-Rybak, M; Lebensztejn, DM; Luczyński, W; Muszyńska-Rosłan, K | 1 |
| Janković, S; Marović, A; Matijaca, M; Pintarić, I; Vlasić-Matas, J | 1 |
| He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG | 1 |
4 review(s) available for lamivudine and cyclosporine
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent advances in the treatment of fulminant hepatitis B].
Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug | 2004 |
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa Acquisita; Esophageal Diseases; Factor VIII; Gastrointestinal Hemorrhage; Glucocorticoids; Hematemesis; Hemophilia A; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Skin | 2017 |
2 trial(s) available for lamivudine and cyclosporine
| Article | Year |
|---|---|
Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.
Topics: Antiviral Agents; Cyclosporine; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Pilot Projects; Virus Replication | 1997 |
Treatment of chronic hepatitis B with lamivudine in renal transplant recipients.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Creatinine; Cyclosporine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Replication | 1998 |
16 other study(ies) available for lamivudine and cyclosporine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
Topics: Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment Outcome | 2000 |
Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
Topics: Adult; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Postoperative Complications; Retrospective Studies | 2000 |
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antiviral Agents; Carrier State; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Recurrence | 2004 |
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.
Topics: Adult; Azathioprine; Caroli Disease; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Infant, Newborn; Lamivudine; Liver; Liver Transplantation; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors | 2005 |
[Immunotherapy in aplastic anaemia as a cause of reactivation of hepatitis B virus-immunologic aspects].
Topics: Anemia, Aplastic; Antigens, CD; Antiviral Agents; Child; Combined Modality Therapy; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Immunotherapy; Interferon-alpha; Lamivudine; Male; Reverse Transcriptase Inhibitors | 2005 |
Neurotoxicity that may mimic progressive multifocal leukoencephalopathy in patient with transplanted kidney.
Topics: Cyclosporine; Female; Humans; Kidney Transplantation; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Middle Aged; Mycophenolic Acid; Neurotoxicity Syndromes | 2007 |